ATE280173T1 - Kristalline form von n,n-dimethyl-3-amino-1- hydroxypropan-1,1-diphosphonsäure mononatriumsalz monohydrat und ein verfahren zu ihrer herstellung - Google Patents

Kristalline form von n,n-dimethyl-3-amino-1- hydroxypropan-1,1-diphosphonsäure mononatriumsalz monohydrat und ein verfahren zu ihrer herstellung

Info

Publication number
ATE280173T1
ATE280173T1 AT98112880T AT98112880T ATE280173T1 AT E280173 T1 ATE280173 T1 AT E280173T1 AT 98112880 T AT98112880 T AT 98112880T AT 98112880 T AT98112880 T AT 98112880T AT E280173 T1 ATE280173 T1 AT E280173T1
Authority
AT
Austria
Prior art keywords
dimethyl
amino
crystalline form
diphosphonic acid
hydroxypropane
Prior art date
Application number
AT98112880T
Other languages
English (en)
Inventor
Adriana Vecchioli
Rafael Labriola
Original Assignee
Gador Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gador Sa filed Critical Gador Sa
Application granted granted Critical
Publication of ATE280173T1 publication Critical patent/ATE280173T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98112880T 1997-07-15 1998-07-10 Kristalline form von n,n-dimethyl-3-amino-1- hydroxypropan-1,1-diphosphonsäure mononatriumsalz monohydrat und ein verfahren zu ihrer herstellung ATE280173T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AR9703155 1997-07-15

Publications (1)

Publication Number Publication Date
ATE280173T1 true ATE280173T1 (de) 2004-11-15

Family

ID=3461022

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98112880T ATE280173T1 (de) 1997-07-15 1998-07-10 Kristalline form von n,n-dimethyl-3-amino-1- hydroxypropan-1,1-diphosphonsäure mononatriumsalz monohydrat und ein verfahren zu ihrer herstellung

Country Status (6)

Country Link
EP (1) EP0891979B1 (de)
AT (1) ATE280173T1 (de)
DE (1) DE69827079T2 (de)
DK (1) DK0891979T3 (de)
ES (1) ES2231919T3 (de)
PT (1) PT891979E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410520B2 (en) * 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
ATE455121T1 (de) * 2001-07-16 2010-01-15 Univ Paris 13 Herstellungsverfahren von derivate von bisphosphonaten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
AU701258B2 (en) * 1994-12-28 1999-01-21 Gador S.A. Bone mass anabolic composition comprising olpadronate

Also Published As

Publication number Publication date
EP0891979A1 (de) 1999-01-20
DE69827079T2 (de) 2005-09-08
DK0891979T3 (da) 2005-01-31
PT891979E (pt) 2005-02-28
ES2231919T3 (es) 2005-05-16
EP0891979B1 (de) 2004-10-20
DE69827079D1 (de) 2004-11-25

Similar Documents

Publication Publication Date Title
ATE129713T1 (de) Kristalline 4-amino-1-hydroxybutyliden-1,1- bisphosphon-säure, verfahren zu ihrer herstellung, zusammensetzungen und deren verwendung.
KR960009411B1 (en) Controlled release preparation containing metoprolol and dihydropyridine
HUT52070A (en) Herbicide compositions containing pyrimidinyl-benzoic acid derivatives as active components, and process for producing the active components
NO302884B1 (no) Krystallinske 3,4,4-trisubstituert-piperidinyl-N-alkylkarboksylater og mellomprodukter, fremgangsmåte for fremstilling av de krystallinske karboksylatene, farmasöytiske preparater inneholdende disse og deres anvendelse
HU9801934D0 (en) Process for producing of herbicidal activity substituted aryl-halogenalkyl-pyrazol derivatives
HU906977D0 (en) Process for producing 2,3-dihydro-2-oxo-1h-imidazo(4,5-b)quinolinyl-oxyalkane-carboxylic acid amides
HUT59558A (en) New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing and utilizing them as antidotum
ATE122045T1 (de) Dc-89-verbindungen und verfahren zu ihrer herstellung.
ES2023509B3 (es) Producto granular (i).
HUT47793A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
ATE118220T1 (de) Kristallines menschliches proinsulin und verfahren zu dessen herstellung.
PT91302A (pt) Processo para a preparacao de composicoes farmaceuticas contendo imidazo {2,1-a} isoquinolinas substituidas por 5-heteroarilo ou 5-arilo
DE69322397T2 (de) Verfahren zur herstellung von kristallinem, stabilem natriumpercarbonat
DE69630609D1 (de) Neue wasserlösliche fluoroethylcamptothecin-derivate und ein verfahren zu ihrer herstellung
ATE280173T1 (de) Kristalline form von n,n-dimethyl-3-amino-1- hydroxypropan-1,1-diphosphonsäure mononatriumsalz monohydrat und ein verfahren zu ihrer herstellung
DE69209166T2 (de) Diclofenac-Cholinsalz, Verfahren zur Herstellung und pharmazeutische Zusammensetzungen, die es enthalten
DE3462331D1 (en) Process for the isolation of 2-naphthylamine-3,6,8-trisulphonic acid as monopotassium or monoammonium salt
HUT56498A (en) Process for producing pharmaceutical compositions having antiviral effect, containing benzylphosphonic acid derivatives
DE3482469D1 (de) N-acyl-anthranilsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
AT363091B (de) Verfahren zur herstellung neuer dibenzo(d,g) (1,3,6)dioxazocin-derivate und ihrer saeureadditionssalze
DE3484040D1 (de) Cyclohexenonderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
AR242792A1 (es) Compuestos de sulfonamida y sales de los mismos, composiciones herbicidas que los contienen y procedimiento para producirlos.
DE69113772D1 (de) 1,4-benzodioxanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE27159T1 (de) Carbapenamverbindung und verfahren zu ihrer herstellung.
HUP9603201A2 (en) Substituted benzene dicarboxylic acid diguanidides, process for producing them, their use for preparing pharmaceutical compositions and diagnostics and pharmaceutical compositions containing the said compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0891979

Country of ref document: EP